| Literature DB >> 3811611 |
Abstract
The combined measles, mumps and rubella live vaccine nowadays available is very well tolerated and confers lifelong immunity. A complete immunization coverage among toddlers, schoolchildren and adolescents should nearly eliminate these three childhood diseases in a given population. The cost/benefit ratio of the immunization is for all three diseases rewarding in Switzerland. Reactions expected to the combined vaccine are mild and complications negligible in comparison to the diseases prevented. Starting in 1987 a nationwide campaign will begin in Switzerland; the aim is to vaccinate next to toddlers all so far non-vaccinated 6-7 years old and 14-15 years old schoolchildren respectively for a period of 8 years.Entities:
Mesh:
Substances:
Year: 1986 PMID: 3811611 DOI: 10.1007/bf02077510
Source DB: PubMed Journal: Soz Praventivmed ISSN: 0303-8408